![](/img/cover-not-exists.png)
A small molecule compound (AVP-13358) in Phase I clinical development suppresses experimental allergy in animals via a distinctly Novel mechanism
Richards, M.L., Ludwig, J., Banie, H., Soneff, R.Y., Marcantonio, D., Chatterjee, A., Scholz, W., Sircar, J.C.Volume:
115
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2004.12.284
Date:
February, 2005
File:
PDF, 33 KB
english, 2005